A carregar...
Immunotherapy in Esophagogastric Adenocarcinoma
Immunotherapy, particular PD-1/L1 inhibition, is a relevant treatment approach in esophagogastric adenocarcinoma. To date, single-agent activity is limited to the chemotherapy refractory setting and molecularly defined subgroups. Currently, ongoing trials, which are likely to relevantly change the l...
Na minha lista:
| Publicado no: | Visc Med |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
S. Karger AG
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6597905/ https://ncbi.nlm.nih.gov/pubmed/31312645 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000497292 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|